Genetic modification of endothelial cells
CA 1340427 C · Owner: Somatix Therapy Corporation · Inventors: Birinyi, Louis K.; Mulligan, Richard C.; Wilson, James Maxwell
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Endothelial cells transduced with genetic material encoding a polypeptide or protein of interest and optionally, a selectable marker, as well as methods for making and using the transduced endothelial cells. Such endothelial cells are useful in improving the performance of vascular grafts and in delivering the encoded polypeptide or protein, such as an enzyme a hormone or a, drug, to an individual who has had a graft or implant of the transduced cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 9, 1999. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 9, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.